

Get the latest on the Aminosyn 3.5 % M, Sulfite Free shortage in 2026. Learn what's causing it, what it costs, and how to find it.
If you rely on Aminosyn 3.5 % M, Sulfite Free as part of your parenteral nutrition, you've likely felt the impact of ongoing drug shortages firsthand. Amino acid injection products — the critical building blocks of IV nutrition — have been in and out of shortage for years, and 2026 is no exception.
In this update, we'll cover the current status of the shortage, what's driving it, how much the medication costs, and what options are available to patients who need it now.
As of early 2026, amino acid injection products remain on the ASHP (American Society of Health-System Pharmacists) drug shortage list. The situation varies by specific product and formulation:
The specific availability of Aminosyn 3.5 % M, Sulfite Free can change week to week. The best way to check current availability is through Medfinder or by contacting your home infusion pharmacy directly.
The shortage of amino acid injection products is driven by several overlapping factors:
Sterile injectable amino acid solutions require specialized manufacturing facilities with strict FDA quality standards. Production disruptions at any single facility can eliminate a significant portion of the national supply. ICU Medical's manufacturing challenges have been a recurring contributor to Aminosyn shortages.
The individual amino acids used as active ingredients come from a limited number of global suppliers. Supply chain disruptions, quality issues with raw materials, or increased global demand can all restrict the availability of these critical components.
In 2021, ICU Medical issued a voluntary nationwide recall of Aminosyn II 15% due to the presence of particulate matter. Recalls like this not only remove existing supply from the market but also divert manufacturing capacity toward replacement production and quality remediation.
The number of patients requiring parenteral nutrition continues to grow, driven by an aging population, increasing rates of gastrointestinal conditions, and expanded use of home parenteral nutrition for chronic conditions like short bowel syndrome and certain cancers.
Aminosyn 3.5 % M, Sulfite Free is primarily an institutional product used in hospitals and through home infusion pharmacies. Pricing can vary significantly depending on the setting:
Most patients don't pay the full cash price out of pocket. Parenteral nutrition is typically covered under medical benefits (not pharmacy benefits), including Medicare Part B for qualifying home PN patients.
While no entirely new amino acid injection products have entered the U.S. market recently, there are developments worth noting:
Your nutrition support team should be aware of these options and can incorporate them into your care plan as needed.
Here are the most effective ways to locate this medication right now:
The Aminosyn 3.5 % M, Sulfite Free shortage has been a persistent challenge for patients and healthcare providers alike. While supply remains inconsistent, there are real strategies and tools available to help you maintain access to the nutrition you need.
Stay proactive: check Medfinder regularly, communicate early and often with your infusion pharmacy, and keep an open dialogue with your healthcare team about alternatives. For more details, read our guides on why Aminosyn is so hard to find, how to find it in stock, and how to save money on parenteral nutrition.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.